Literature DB >> 1696882

Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy.

M L Davenport1, D R Clemmons, M V Miles, C Camacho-Hubner, A J D'Ercole, L E Underwood.   

Abstract

Serum concentrations of insulin-like growth factor-I (IGF-I) in rats are reduced dramatically in the latter half of pregnancy, decreasing from 1758 +/- 356 ng/ml at 12 days of pregnancy (mean +/- SD) to 761 +/- 192 ng/ml at 15 days. After parturition, IGF-I increases to nonpregnant values in 4 days. Using ligand blotting, we have demonstrated that most of the serum IGF binding proteins (IGFBPs) are concurrently reduced during pregnancy. IGFBP-3, the predominant IGFBP in nonpregnant serum, is reduced to 1.3% of nonpregnant values by 21 days of pregnancy and begins to rise within 1 h postpartum (PP). The sera of 21-day pregnant (but not nonpregnant) rats degrade IGFBP-3 in vitro, and this degradation is prevented by the protease inhibitor antipain. Decreased serum IGF-I concentrations during pregnancy, therefore, may result from reduced IGFBP-3 concentrations causing increased IGF-I clearance. In addition, steady state IGF-I mRNA and peptide levels in liver are decreased in 21-day pregnant rats (37% and 42% of 4 day PP levels, respectively), suggesting that decreased synthesis of IGF-I may also lead to lower serum IGF-I concentrations. After bolus injection, [125I]IGF-I is cleared from the serum of pregnant rats nearly 5 times faster than that of 4 day PP rats (1.21 vs. 0.25 ml/min/kg, respectively). Urinary clearance is relatively insignificant (less than 4%), and [125I]IGF-I does not cross the placenta. The intermediate distribution phase of IGF-I is slower in pregnant rats than in PP rats (t1/2 alpha, 17.1 vs. 5.4 min), whereas the terminal elimination of IGF-I is twice as fast (t1/2 beta, 228.1 vs. 106.4 min). The prolonged IGF-I distribution phase in the pregnant rats may result from decreased concentrations of 34,000 and 30,000 mol wt IGFBPs, which may transport IGF-I to tissues. The faster serum elimination half-life may result from diminished IGFBP-3, leading to greater IGF-I availability to tissues in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696882     DOI: 10.1210/endo-127-3-1278

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

Review 1.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

2.  Decrease in the glycosaminoglycan content in the skin of diabetic rats. The role of IGF-I, IGF-binding proteins and proteolytic activity.

Authors:  M Cechowska-Pasko; J Pałka; E Bańkowski
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

3.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  Insulin-like growth factor-II regulates maternal hemodynamic adaptation to pregnancy in rats.

Authors:  Tim Van Mieghem; Rita van Bree; Erik Van Herck; Jan Deprest; Johan Verhaeghe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-23       Impact factor: 3.619

5.  Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia.

Authors:  Oussama Grissa; Akadiri Yessoufou; Inès Mrisak; Aziz Hichami; Daniel Amoussou-Guenou; Abir Grissa; François Djrolo; Kabir Moutairou; Abdelhedi Miled; Hédi Khairi; Monia Zaouali; Iheb Bougmiza; Aabdelkarim Zbidi; Zouheir Tabka; Naim A Khan
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-09       Impact factor: 3.007

6.  Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum.

Authors:  R C Baxter; A M Suikkari; J L Martin
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  Prenatal modulation of breast density and breast stem cells by insulin-like growth factor-1.

Authors:  Chien-I Chang; Hoi Pang Low; Li Qiu; William C Strohsnitter; Chung-Cheng Hsieh
Journal:  Am J Stem Cells       Date:  2012-11-30

8.  Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence.

Authors:  J I Jones; A Gockerman; W H Busby; G Wright; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

9.  Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.

Authors:  G Scirè; C Del Bianco; G L Spadoni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

10.  The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.

Authors:  R G Douglas; P D Gluckman; K Ball; B Breier; J H Shaw
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.